Diabetes Type 1 and Type 2—a Study on Country-wise Disease Demographics
The pervasiveness of diabetes type 1 and type 2 has had a notable impact on people's well-being and hampered the healthcare system's sustainability. A study forecasts that around 783.7 million people will live with diabetes by 2045. Strain diabetes puts on the economy and the complications linked to the disease have warranted a holistic approach to develop strategies to minimize prevalence and foster healthcare. There is a general acceptance that physical activity and healthy food habits could reduce obesity rates and diabetes risks.
Researchers, manufacturers and other stakeholders are navigating growth and opportunities in diabetes devices and treatment. The development of advanced treatment options could be pronounced amid the aging population. A healthy lifestyle and better diabetes medications are expected to make a difference in minimizing diabetes. The final report, coupled with the database, will deep-dive into the following dynamics:
• Decision-making process and customer buying pattern.
• Reimbursement landscape and diabetes-related expenditure per person.
• Treatment options and related costs across countries.
• Comparative prevalence of diabetes.
Get your copy or request a free sample of the report “Disease Demographics for Diabetes Type 1 and Type 2, 2023,” compiled and published by Grand View Research.
Disease Demographics for Diabetes Type 1 and Type 2 Report Scope
|
Attribute |
Details |
|
Patient Demographics |
|
|
Treatment Options |
|
|
Treatment Cost Per Patient |
|
|
Quality of Life |
|
|
Comorbidity Analysis |
|
|
Reimbursement Differences |
|
|
Regions |
|
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian